Saverio Danese

Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study

Sabino De Placido, Giovanni Scambia, Giovanni Di Vagno et al. · Journal of Clinical Oncology · 2004 · 165 citations · Full text

Medicine, Oncology, Pharmacology +15

Outcome of Patients with HER2-Positive Advanced Breast Cancer Progressing During Trastuzumab-Based Therapy

Filippo Montemurro, Michela Donadio, Matteo Clavarezza et al. · The Oncologist · 2006 · 128 citations · Full text

Medicine, Oncology, Pharmacology +16

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

Sandro Pignata, Sabino De Placido, R. Biamonte et al. · BMC Cancer · 2006 · 115 citations · Full text

Medicine, Oncology, Pharmacology +17

Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design

Alfredo Berruti, Raffaella Bitossi, G. Gorzegno et al. · Journal of Clinical Oncology · 2002 · 83 citations

Medicine, Oncology, Pharmacology +16

Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel

Dan Su, Stephanie M. Smith, Mario Preti et al. · Cancer · 2009 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17